The Center for Precision Medicine for High-risk Pediatric Cancer Frontier Program builds upon ongoing precision medicine efforts across CHOP departments to define and expand treatment options.
The Children’s Hospital of Philadelphia and four other high-profile oncology research programs plus a coordinating center joined the new Pediatric Preclinical Testing Consortium (PPTC) launched by the National Cancer Institute (NCI) to help researchers identify drug candidates for pediatric clinical trials.
Check it out! A report on American Public Media's Marketplace on DNA sequencing and its effect on (and creation of) personalized medicine - "the next big thing in health care" - featured input from CHOP's Nancy B. Spinner, PhD.
Personalized medicine: it's all about you. The idea of "personalized" medicine isn't just about a one-on-one encounter with a doctor, the use of sophisticated mobile applications, or heightened access to healthcare providers, medical records, and services. Personalized medicine also extends into the depths of who each of us are at our essence - to our individual genetic makeup.
